This blog is based on the recent Frost & Sullivan analysis, “United States Clinical Laboratory Services Growth Opportunities, forecast 2030,” authored by Chandni Hussain, Industry Analyst, Healthcare & Life Sciences Practice.
Clinical laboratories are processing more tests than ever before as aging populations, rising chronic disease prevalence, and advances in precision medicine and molecular diagnostics reshape healthcare delivery. However, increasing testing volumes alone will not define the next phase of US clinical laboratory services. Laboratories must also navigate reimbursement pressures, evolving regulatory requirements, payer consolidation, and growing demand for faster, more efficient diagnostic services.
The US clinical laboratory services market is projected to grow from $130.88 billion in 2024 to $175.13 billion by 2030, at a 5.0% CAGR. To support rising demand while maintaining operational efficiency, laboratories are investing in laboratory automation, digital workflows, advanced diagnostics, and optimized service portfolios.
Strengthen Your Clinical Laboratory Strategy
Explore the strategic imperatives and growth opportunities driving the future of US clinical laboratory services.
As testing volumes grow and diagnostic complexity increases, is your laboratory equipped to keep pace?
Strategic Imperatives Redefining US Clinical Laboratory Services
Disruptive Technologies
Clinical laboratories are using advanced tools like genomics, proteomics, real-time polymerase chain reaction (PCR), companion diagnostics, and precision medicine to improve diagnostic accuracy and support earlier disease detection. These technologies also enable more accurate pathogen identification and streamline laboratory workflows through digital integration.
Customer Value Chain Compression
Testing is moving closer to patients as demand grows for faster and more convenient access. Point-of-care testing (POCT), retail clinic collection, at-home kits, telehealth ordering, and digital result delivery are pushing laboratories beyond traditional centralized models.
Competitive Intensity
Larger laboratories are expanding through mergers, digital access, and retail partnerships, while independent laboratories face increasing pressure from reimbursement changes, payer policies, and referral restrictions. This is shifting competition toward faster turnaround times, stronger digital capabilities, and broader diagnostic access rather than price alone.
Which growth strategies will help your teams adapt to these industry headwinds?
Clinical Laboratory Services: At a Glance
What’s Driving Growth in the Clinical Laboratory Services Market?
- Clinical Informatics and Healthcare Data: Growing volumes of clinical data are increasing demand for integrated diagnostics, predictive analytics, and companion diagnostics.
- Next-generation Sequencing (NGS): Broader payer coverage and lower testing costs are expanding the use of NGS and molecular pathology for infectious diseases, cancer, and genetic disorders.
- AI-driven Laboratory Automation: Investments in AI, robotics, and Laboratory Information System (LIS) integration are improving throughput, reducing turnaround times, and supporting digital laboratory workflows.
- Point-of-care and At-home Testing: Point-of-care testing (POCT), at-home diagnostics, and retail healthcare partnerships are making routine laboratory testing more accessible and convenient.
- Reimbursement and Healthcare Consolidation: Payer scrutiny, value-based reimbursement models, and healthcare consolidation are encouraging laboratories to improve efficiency and strengthen service delivery.
What’s Slowing Market Growth?
- Laboratory Developed Test (LDT) Regulations: The US Food and Drug Administration (FDA)’s final rule on LDT regulations is increasing compliance and validation requirements. Smaller and specialized laboratories are facing higher costs and longer test adoption timelines.
- Medical Technologist Shortages: Retirements continue to outpace new hires, creating persistent staffing shortages across the industry. Automation and outsourcing help ease the gap, but workforce shortages remain.
- Rising Technology Investment Costs: Laboratories continue to invest in analyzers, automation systems, and IT infrastructure. Lower reimbursements, inflation, and limited access to funding are making these investments more challenging for smaller and regional laboratories.
- Interoperability Challenges: Data silos and interoperability issues continue to slow the adoption of advanced analytics and laboratory automation. Cybersecurity concerns further complicate digital integration.
- Fragmented Data Standards: The lack of standardized test ordering and data exchange creates additional administrative work. It also leads to duplicate testing, billing delays, and compliance challenges across laboratory networks.
The Competitive Landscape: Who’s Setting the Pace?
The US clinical laboratory services industry is shaped by large national laboratory networks and specialized diagnostic providers. National networks compete on scale and logistics, while specialized laboratories are driving innovation in molecular diagnostics, genomics, and precision medicine.
What sets industry leaders apart?
- Advanced diagnostic portfolios with growing investments in genomics, molecular diagnostics, and companion diagnostics.
- Digital laboratory operations that combine AI, robotics, and automation to improve efficiency and turnaround times.
- Broader patient access through retail partnerships, home collection, and decentralized testing models.
Companies to Action:
- Labcorp has expanded its specialty diagnostics portfolio while strengthening its retail and home collection network.
- Quest Diagnostics is advancing AI-enabled laboratory operations to improve efficiency and faster sample processing.
- Natera is expanding cell-free DNA and organ health testing as reimbursement for genomics continues to grow.
Where to Invest: Growth Opportunities in Clinical Laboratory Services
- Expand Specialized Diagnostic Services Beyond Acute and Oncology Testing
The growing burden of chronic diseases and an aging population are increasing demand for specialized diagnostics. Leading laboratories are expanding disease-specific portfolios, while advances in biomarker and proteomic testing are improving early diagnosis across cardiovascular, neurodegenerative, metabolic, and other chronic conditions.
Why Specialized Diagnostics?
- Higher-value tests such as pharmacogenomics (PGx), biomarker panels, and advanced allergy testing increase revenue per requisition.
- Specialized diagnostics typically generate stronger margins than routine laboratory testing.
- Partnerships with Accountable Care Organizations (ACOs) and Medicare Advantage plans support value-based diagnostic programs.
- Build Decentralized and Home-based Diagnostic Networks
Demand for faster and more convenient testing is accelerating the shift from centralized laboratories to home-based, retail, and near-patient diagnostic models. Advances in Clinical Laboratory Improvement Amendments (CLIA)-waived devices, lab-on-chip technologies, and AI-supported interpretation, together with expanding telehealth adoption, are making reliable diagnostics more accessible beyond traditional laboratory settings.
Why Decentralized Diagnostics?
- Hybrid diagnostic models combine centralized laboratory quality with decentralized testing access.
- Direct-to-consumer wellness panels create additional self-pay revenue opportunities.
- Regional processing hubs and mobile diagnostic units reduce turnaround times.
- Retail and telehealth partnerships extend diagnostic access beyond traditional laboratories.
Which of these opportunities will have the maximum impact on your organization, and how will you measure it?
The Future of Clinical Laboratory Services
The next phase of clinical laboratory services will extend beyond processing higher testing volumes. Growth will come from specialized diagnostics, integrated operations, and diagnostic networks that improve access across hospitals, retail settings, and home-based care. Laboratories that adapt to these shifts will be better aligned with the evolving needs of patients, providers, and payers.
Frequently Asked Questions (FAQs)
What is a clinical laboratory service?
A clinical laboratory service is a diagnostic service that analyzes patient samples, such as blood, urine, and tissue, to detect diseases, monitor health conditions, and support medical decisions. These services include routine testing, molecular diagnostics, pathology, and specialized diagnostic testing.
What does a clinical laboratory do?
A clinical laboratory tests biological samples to diagnose diseases, monitor treatment outcomes, and assess patient health. Laboratories perform tests in areas such as clinical chemistry, hematology, microbiology, molecular diagnostics, and genetic testing to provide physicians with diagnostic insights.
What are the trends in the clinical laboratory industry?
Major trends in the clinical laboratory industry include the adoption of laboratory automation, molecular diagnostics, precision medicine, point-of-care testing, and decentralized diagnostics. Laboratories are also expanding specialized testing capabilities and using digital technologies to improve efficiency, access, and diagnostic decision-making.
What is the most common molecular diagnostic test?
Polymerase chain reaction (PCR) is one of the most common molecular diagnostic tests. It detects genetic material from pathogens or human cells and is widely used for infectious disease testing, genetic analysis, and other applications requiring rapid and accurate molecular detection.
Ready to Lead the Transformation?
- Schedule a Growth Strategy Dialog:Align your growth roadmap with Frost & Sullivan’s Visionary Growth Pipeline™ Dialog.
- Engage with Growth Experts:Co-design AI-enabled, data-driven operating models that scale industry-specific and commercial impact.
- Showcase Your Transformational Leadership: Position your organization as a transformation leader through Frost & Sullivan’s Transformational Growth Leadership platform.
- Join the Growth Council:Collaborate with industry leaders shaping the future of your ecosystem.
- Explore Best Practices Recognition:Be recognized for excellence in growth strategy, execution, and customer impact.
- Benchmark Your Industry Positioning on the Frost Radar™:Benchmark your growth performance and innovation strength against industry competitors.
- Tell Your Story:Accelerate awareness, engagement, and revenue growth through integrated brand and demand generation strategies.
